The inhibitory effect of lidocaine hydrochloride salt on duodenal peristalsis during ERCP:a muiticenter, randomized, placebo-controlled trial.
Phase 3
Recruiting
- Conditions
- Acute cholangitis,Obstructive jaundice,Pancreatic cancer,IPM
- Registration Number
- JPRN-jRCTs031190059
- Lead Sponsor
- Hosono Kunihiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1.over the age of 65 under the age of 90
2.Adaptation of ERCP
3.Score of peristalsis 1-3
4.Written informed consent
Exclusion Criteria
1.Acute pancreatitis
2.Allergy of Amide-type local anesthetic allergy
3.Altered upper GI anatomy
4.Pregnant,unwilling to practice contraception during the study, or lactating female
5.Heart stimulus conduction disorders
6.severe liver or kidney dysfunction
7.score of peristalsis:4,5
8.A patient who has judged to be inappropriate as a target by the judgement of the practitioner
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ceased peristalsis
- Secondary Outcome Measures
Name Time Method Required time,Stop duration time,Adverese events